Global Nuclear Medicine Cyclotron Systems Market Growth 2025-2031

April 2025 | 86 pages | ID: GA803EE50269EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global Corrosion Under Insulation (CUI) Monitoring market size is predicted to grow from US$ 214 million in 2025 to US$ 260 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.

Corrosion under insulation (CUI) poses a significant operational loss, safety hazard and economic cost. Corrosion under insulation (CUI) is invisible to the surface of the insulation. Because of this, it is very difficult for conventional techniques to detect and monitor corrosion under insulation. The presence of moisture in and under insulation is the root cause of corrosion under insulation (CUI). Corrosion under insulation is a severe form of localized external corrosion that occurs in carbon and low alloy steel equipment that has been insulated. This form of corrosion occurs when water is absorbed by or collected in the insulation. As a result he equipment begins to corrode as it is exposed to water and oxygen. Depending on the structure and the location of the insulation, CUI can attack the jacketing, insulation hardware or underlying piping equipment. Additionally, when insulation becomes wet or absorbs moisture, its thermal insulating properties are drastically reduced. Because water conducts heat more efficiently than air, an aggressive corrosion cell is created where the trapped heat accelerates the rate of corrosion.

Global key players of Corrosion Under Insulation (CUI) Monitoring include Mistras, QSA Global, Inc. , Previan (Eddyfi), Kaefer Group, Alabama Specialty Products (Metal Samples) and Applied Technical Services, LLC, etc. The top six manufacturers hold a share over 65%.

LPI (LP Information)' newest research report, the “Corrosion Under Insulation (CUI) Monitoring Industry Forecast” looks at past sales and reviews total world Corrosion Under Insulation (CUI) Monitoring sales in 2024, providing a comprehensive analysis by region and market sector of projected Corrosion Under Insulation (CUI) Monitoring sales for 2025 through 2031. With Corrosion Under Insulation (CUI) Monitoring sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Corrosion Under Insulation (CUI) Monitoring industry.

This Insight Report provides a comprehensive analysis of the global Corrosion Under Insulation (CUI) Monitoring landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Corrosion Under Insulation (CUI) Monitoring portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Corrosion Under Insulation (CUI) Monitoring market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Corrosion Under Insulation (CUI) Monitoring and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Corrosion Under Insulation (CUI) Monitoring.

This report presents a comprehensive overview, market shares, and growth opportunities of Corrosion Under Insulation (CUI) Monitoring market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • Hardware
  • Software
  • Services
Segmentation by Application:
  • Oil & Gas
  • Marine
  • Chemical & Petrochemical
  • Energy & Power
  • Food Processing Industries
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Mistras
  • QSA Global, Inc.
  • Previan (Eddyfi)
  • Kaefer Group
  • Alabama Specialty Products (Metal Samples)
  • Applied Technical Services, LLC
  • Testex Inc
  • Rohrback Cosasco Systems (RCS)
  • 3-Sci Limited
  • CorrosionRADAR
  • iSensPro
  • ESR Technology
  • Maxwell NDT
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nuclear Medicine Cyclotron Systems Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Nuclear Medicine Cyclotron Systems by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Nuclear Medicine Cyclotron Systems by Country/Region, 2020, 2024 & 2031
2.2 Nuclear Medicine Cyclotron Systems Segment by Type
  2.2.1 Cyclotron Less than 12 MeV
  2.2.2 Cyclotron 13-18 MeV
  2.2.3 Cyclotron 19-24 MeV
  2.2.4 Cyclotron More than 24 MeV
2.3 Nuclear Medicine Cyclotron Systems Sales by Type
  2.3.1 Global Nuclear Medicine Cyclotron Systems Sales Market Share by Type (2020-2025)
  2.3.2 Global Nuclear Medicine Cyclotron Systems Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Nuclear Medicine Cyclotron Systems Sale Price by Type (2020-2025)
2.4 Nuclear Medicine Cyclotron Systems Segment by Application
  2.4.1 Pharmaceutical Industry
  2.4.2 Hospital
  2.4.3 Research & Academics
2.5 Nuclear Medicine Cyclotron Systems Sales by Application
  2.5.1 Global Nuclear Medicine Cyclotron Systems Sale Market Share by Application (2020-2025)
  2.5.2 Global Nuclear Medicine Cyclotron Systems Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Nuclear Medicine Cyclotron Systems Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Nuclear Medicine Cyclotron Systems Breakdown Data by Company
  3.1.1 Global Nuclear Medicine Cyclotron Systems Annual Sales by Company (2020-2025)
  3.1.2 Global Nuclear Medicine Cyclotron Systems Sales Market Share by Company (2020-2025)
3.2 Global Nuclear Medicine Cyclotron Systems Annual Revenue by Company (2020-2025)
  3.2.1 Global Nuclear Medicine Cyclotron Systems Revenue by Company (2020-2025)
  3.2.2 Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Company (2020-2025)
3.3 Global Nuclear Medicine Cyclotron Systems Sale Price by Company
3.4 Key Manufacturers Nuclear Medicine Cyclotron Systems Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Nuclear Medicine Cyclotron Systems Product Location Distribution
  3.4.2 Players Nuclear Medicine Cyclotron Systems Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NUCLEAR MEDICINE CYCLOTRON SYSTEMS BY GEOGRAPHIC REGION

4.1 World Historic Nuclear Medicine Cyclotron Systems Market Size by Geographic Region (2020-2025)
  4.1.1 Global Nuclear Medicine Cyclotron Systems Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Nuclear Medicine Cyclotron Systems Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Nuclear Medicine Cyclotron Systems Market Size by Country/Region (2020-2025)
  4.2.1 Global Nuclear Medicine Cyclotron Systems Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Nuclear Medicine Cyclotron Systems Annual Revenue by Country/Region (2020-2025)
4.3 Americas Nuclear Medicine Cyclotron Systems Sales Growth
4.4 APAC Nuclear Medicine Cyclotron Systems Sales Growth
4.5 Europe Nuclear Medicine Cyclotron Systems Sales Growth
4.6 Middle East & Africa Nuclear Medicine Cyclotron Systems Sales Growth

5 AMERICAS

5.1 Americas Nuclear Medicine Cyclotron Systems Sales by Country
  5.1.1 Americas Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025)
  5.1.2 Americas Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025)
5.2 Americas Nuclear Medicine Cyclotron Systems Sales by Type (2020-2025)
5.3 Americas Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nuclear Medicine Cyclotron Systems Sales by Region
  6.1.1 APAC Nuclear Medicine Cyclotron Systems Sales by Region (2020-2025)
  6.1.2 APAC Nuclear Medicine Cyclotron Systems Revenue by Region (2020-2025)
6.2 APAC Nuclear Medicine Cyclotron Systems Sales by Type (2020-2025)
6.3 APAC Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Nuclear Medicine Cyclotron Systems by Country
  7.1.1 Europe Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025)
  7.1.2 Europe Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025)
7.2 Europe Nuclear Medicine Cyclotron Systems Sales by Type (2020-2025)
7.3 Europe Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nuclear Medicine Cyclotron Systems by Country
  8.1.1 Middle East & Africa Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025)
8.2 Middle East & Africa Nuclear Medicine Cyclotron Systems Sales by Type (2020-2025)
8.3 Middle East & Africa Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine Cyclotron Systems
10.3 Manufacturing Process Analysis of Nuclear Medicine Cyclotron Systems
10.4 Industry Chain Structure of Nuclear Medicine Cyclotron Systems

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Nuclear Medicine Cyclotron Systems Distributors
11.3 Nuclear Medicine Cyclotron Systems Customer

12 WORLD FORECAST REVIEW FOR NUCLEAR MEDICINE CYCLOTRON SYSTEMS BY GEOGRAPHIC REGION

12.1 Global Nuclear Medicine Cyclotron Systems Market Size Forecast by Region
  12.1.1 Global Nuclear Medicine Cyclotron Systems Forecast by Region (2026-2031)
  12.1.2 Global Nuclear Medicine Cyclotron Systems Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Nuclear Medicine Cyclotron Systems Forecast by Type (2026-2031)
12.7 Global Nuclear Medicine Cyclotron Systems Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 GE Healthcare
  13.1.1 GE Healthcare Company Information
  13.1.2 GE Healthcare Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
  13.1.3 GE Healthcare Nuclear Medicine Cyclotron Systems Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 GE Healthcare Main Business Overview
  13.1.5 GE Healthcare Latest Developments
13.2 IBA
  13.2.1 IBA Company Information
  13.2.2 IBA Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
  13.2.3 IBA Nuclear Medicine Cyclotron Systems Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 IBA Main Business Overview
  13.2.5 IBA Latest Developments
13.3 Best Cyclotron Systems
  13.3.1 Best Cyclotron Systems Company Information
  13.3.2 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
  13.3.3 Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Best Cyclotron Systems Main Business Overview
  13.3.5 Best Cyclotron Systems Latest Developments
13.4 Advanced Cyclotron Systems (ACSI)
  13.4.1 Advanced Cyclotron Systems (ACSI) Company Information
  13.4.2 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
  13.4.3 Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Advanced Cyclotron Systems (ACSI) Main Business Overview
  13.4.5 Advanced Cyclotron Systems (ACSI) Latest Developments
13.5 Sumitomo Heavy Industries
  13.5.1 Sumitomo Heavy Industries Company Information
  13.5.2 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
  13.5.3 Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Sumitomo Heavy Industries Main Business Overview
  13.5.5 Sumitomo Heavy Industries Latest Developments
13.6 Longevous Beamtech
  13.6.1 Longevous Beamtech Company Information
  13.6.2 Longevous Beamtech Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
  13.6.3 Longevous Beamtech Nuclear Medicine Cyclotron Systems Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Longevous Beamtech Main Business Overview
  13.6.5 Longevous Beamtech Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Nuclear Medicine Cyclotron Systems Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Nuclear Medicine Cyclotron Systems Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Cyclotron Less than 12 MeV
Table 4. Major Players of Cyclotron 13-18 MeV
Table 5. Major Players of Cyclotron 19-24 MeV
Table 6. Major Players of Cyclotron More than 24 MeV
Table 7. Global Nuclear Medicine Cyclotron Systems Sales byType (2020-2025) & (Units)
Table 8. Global Nuclear Medicine Cyclotron Systems Sales Market Share byType (2020-2025)
Table 9. Global Nuclear Medicine Cyclotron Systems Revenue byType (2020-2025) & ($ million)
Table 10. Global Nuclear Medicine Cyclotron Systems Revenue Market Share byType (2020-2025)
Table 11. Global Nuclear Medicine Cyclotron Systems Sale Price byType (2020-2025) & (M US$/Unit)
Table 12. Global Nuclear Medicine Cyclotron Systems Sale by Application (2020-2025) & (Units)
Table 13. Global Nuclear Medicine Cyclotron Systems Sale Market Share by Application (2020-2025)
Table 14. Global Nuclear Medicine Cyclotron Systems Revenue by Application (2020-2025) & ($ million)
Table 15. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Application (2020-2025)
Table 16. Global Nuclear Medicine Cyclotron Systems Sale Price by Application (2020-2025) & (M US$/Unit)
Table 17. Global Nuclear Medicine Cyclotron Systems Sales by Company (2020-2025) & (Units)
Table 18. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Company (2020-2025)
Table 19. Global Nuclear Medicine Cyclotron Systems Revenue by Company (2020-2025) & ($ millions)
Table 20. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Company (2020-2025)
Table 21. Global Nuclear Medicine Cyclotron Systems Sale Price by Company (2020-2025) & (M US$/Unit)
Table 22. Key Manufacturers Nuclear Medicine Cyclotron Systems Producing Area Distribution and Sales Area
Table 23. Players Nuclear Medicine Cyclotron Systems Products Offered
Table 24. Nuclear Medicine Cyclotron Systems Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Nuclear Medicine Cyclotron Systems Sales by Geographic Region (2020-2025) & (Units)
Table 28. Global Nuclear Medicine Cyclotron Systems Sales Market Share Geographic Region (2020-2025)
Table 29. Global Nuclear Medicine Cyclotron Systems Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Geographic Region (2020-2025)
Table 31. Global Nuclear Medicine Cyclotron Systems Sales by Country/Region (2020-2025) & (Units)
Table 32. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Country/Region (2020-2025)
Table 33. Global Nuclear Medicine Cyclotron Systems Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Country/Region (2020-2025)
Table 35. Americas Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025) & (Units)
Table 36. Americas Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2020-2025)
Table 37. Americas Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025) & ($ millions)
Table 38. Americas Nuclear Medicine Cyclotron Systems Sales byType (2020-2025) & (Units)
Table 39. Americas Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025) & (Units)
Table 40. APAC Nuclear Medicine Cyclotron Systems Sales by Region (2020-2025) & (Units)
Table 41. APAC Nuclear Medicine Cyclotron Systems Sales Market Share by Region (2020-2025)
Table 42. APAC Nuclear Medicine Cyclotron Systems Revenue by Region (2020-2025) & ($ millions)
Table 43. APAC Nuclear Medicine Cyclotron Systems Sales byType (2020-2025) & (Units)
Table 44. APAC Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025) & (Units)
Table 45. Europe Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025) & (Units)
Table 46. Europe Nuclear Medicine Cyclotron Systems Revenue by Country (2020-2025) & ($ millions)
Table 47. Europe Nuclear Medicine Cyclotron Systems Sales byType (2020-2025) & (Units)
Table 48. Europe Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025) & (Units)
Table 49. Middle East & Africa Nuclear Medicine Cyclotron Systems Sales by Country (2020-2025) & (Units)
Table 50. Middle East & Africa Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2020-2025)
Table 51. Middle East & Africa Nuclear Medicine Cyclotron Systems Sales byType (2020-2025) & (Units)
Table 52. Middle East & Africa Nuclear Medicine Cyclotron Systems Sales by Application (2020-2025) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Nuclear Medicine Cyclotron Systems
Table 54. Key Market Challenges & Risks of Nuclear Medicine Cyclotron Systems
Table 55. Key IndustryTrends of Nuclear Medicine Cyclotron Systems
Table 56. Nuclear Medicine Cyclotron Systems Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Nuclear Medicine Cyclotron Systems Distributors List
Table 59. Nuclear Medicine Cyclotron Systems Customer List
Table 60. Global Nuclear Medicine Cyclotron Systems SalesForecast by Region (2026-2031) & (Units)
Table 61. Global Nuclear Medicine Cyclotron Systems RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. Americas Nuclear Medicine Cyclotron Systems SalesForecast by Country (2026-2031) & (Units)
Table 63. Americas Nuclear Medicine Cyclotron Systems Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APAC Nuclear Medicine Cyclotron Systems SalesForecast by Region (2026-2031) & (Units)
Table 65. APAC Nuclear Medicine Cyclotron Systems Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. Europe Nuclear Medicine Cyclotron Systems SalesForecast by Country (2026-2031) & (Units)
Table 67. Europe Nuclear Medicine Cyclotron Systems RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & Africa Nuclear Medicine Cyclotron Systems SalesForecast by Country (2026-2031) & (Units)
Table 69. Middle East & Africa Nuclear Medicine Cyclotron Systems RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. Global Nuclear Medicine Cyclotron Systems SalesForecast byType (2026-2031) & (Units)
Table 71. Global Nuclear Medicine Cyclotron Systems RevenueForecast byType (2026-2031) & ($ millions)
Table 72. Global Nuclear Medicine Cyclotron Systems SalesForecast by Application (2026-2031) & (Units)
Table 73. Global Nuclear Medicine Cyclotron Systems RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. GE Healthcare Basic Information, Nuclear Medicine Cyclotron Systems Manufacturing Base, Sales Area and Its Competitors
Table 75. GE Healthcare Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
Table 76. GE Healthcare Nuclear Medicine Cyclotron Systems Sales (Units), Revenue ($ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
Table 77. GE Healthcare Main Business
Table 78. GE Healthcare Latest Developments
Table 79. IBA Basic Information, Nuclear Medicine Cyclotron Systems Manufacturing Base, Sales Area and Its Competitors
Table 80. IBA Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
Table 81. IBA Nuclear Medicine Cyclotron Systems Sales (Units), Revenue ($ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
Table 82. IBA Main Business
Table 83. IBA Latest Developments
Table 84. Best Cyclotron Systems Basic Information, Nuclear Medicine Cyclotron Systems Manufacturing Base, Sales Area and Its Competitors
Table 85. Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
Table 86. Best Cyclotron Systems Nuclear Medicine Cyclotron Systems Sales (Units), Revenue ($ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
Table 87. Best Cyclotron Systems Main Business
Table 88. Best Cyclotron Systems Latest Developments
Table 89. Advanced Cyclotron Systems (ACSI) Basic Information, Nuclear Medicine Cyclotron Systems Manufacturing Base, Sales Area and Its Competitors
Table 90. Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
Table 91. Advanced Cyclotron Systems (ACSI) Nuclear Medicine Cyclotron Systems Sales (Units), Revenue ($ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
Table 92. Advanced Cyclotron Systems (ACSI) Main Business
Table 93. Advanced Cyclotron Systems (ACSI) Latest Developments
Table 94. Sumitomo Heavy Industries Basic Information, Nuclear Medicine Cyclotron Systems Manufacturing Base, Sales Area and Its Competitors
Table 95. Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
Table 96. Sumitomo Heavy Industries Nuclear Medicine Cyclotron Systems Sales (Units), Revenue ($ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
Table 97. Sumitomo Heavy Industries Main Business
Table 98. Sumitomo Heavy Industries Latest Developments
Table 99. Longevous Beamtech Basic Information, Nuclear Medicine Cyclotron Systems Manufacturing Base, Sales Area and Its Competitors
Table 100. Longevous Beamtech Nuclear Medicine Cyclotron Systems Product Portfolios and Specifications
Table 101. Longevous Beamtech Nuclear Medicine Cyclotron Systems Sales (Units), Revenue ($ Million), Price (M US$/Unit) and Gross Margin (2020-2025)
Table 102. Longevous Beamtech Main Business
Table 103. Longevous Beamtech Latest Developments



LIST OF FIGURES

Figure 1. Picture of Nuclear Medicine Cyclotron Systems
Figure 2. Nuclear Medicine Cyclotron Systems Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Medicine Cyclotron Systems Sales Growth Rate 2020-2031 (Units)
Figure 7. Global Nuclear Medicine Cyclotron Systems Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Nuclear Medicine Cyclotron Systems Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Nuclear Medicine Cyclotron Systems Sales Market Share by Country/Region (2024)
Figure 10. Nuclear Medicine Cyclotron Systems Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Cyclotron Less than 12 MeV
Figure 12. Product Picture of Cyclotron 13-18 MeV
Figure 13. Product Picture of Cyclotron 19-24 MeV
Figure 14. Product Picture of Cyclotron More than 24 MeV
Figure 15. Global Nuclear Medicine Cyclotron Systems Sales Market Share byType in 2025
Figure 16. Global Nuclear Medicine Cyclotron Systems Revenue Market Share byType (2020-2025)
Figure 17. Nuclear Medicine Cyclotron Systems Consumed in Pharmaceutical Industry
Figure 18. Global Nuclear Medicine Cyclotron Systems Market: Pharmaceutical Industry (2020-2025) & (Units)
Figure 19. Nuclear Medicine Cyclotron Systems Consumed in Hospital
Figure 20. Global Nuclear Medicine Cyclotron Systems Market: Hospital (2020-2025) & (Units)
Figure 21. Nuclear Medicine Cyclotron Systems Consumed in Research & Academics
Figure 22. Global Nuclear Medicine Cyclotron Systems Market: Research & Academics (2020-2025) & (Units)
Figure 23. Global Nuclear Medicine Cyclotron Systems Sale Market Share by Application (2024)
Figure 24. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Application in 2025
Figure 25. Nuclear Medicine Cyclotron Systems Sales by Company in 2025 (Units)
Figure 26. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Company in 2025
Figure 27. Nuclear Medicine Cyclotron Systems Revenue by Company in 2025 ($ millions)
Figure 28. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Company in 2025
Figure 29. Global Nuclear Medicine Cyclotron Systems Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Nuclear Medicine Cyclotron Systems Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Nuclear Medicine Cyclotron Systems Sales 2020-2025 (Units)
Figure 32. Americas Nuclear Medicine Cyclotron Systems Revenue 2020-2025 ($ millions)
Figure 33. APAC Nuclear Medicine Cyclotron Systems Sales 2020-2025 (Units)
Figure 34. APAC Nuclear Medicine Cyclotron Systems Revenue 2020-2025 ($ millions)
Figure 35. Europe Nuclear Medicine Cyclotron Systems Sales 2020-2025 (Units)
Figure 36. Europe Nuclear Medicine Cyclotron Systems Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Nuclear Medicine Cyclotron Systems Sales 2020-2025 (Units)
Figure 38. Middle East & Africa Nuclear Medicine Cyclotron Systems Revenue 2020-2025 ($ millions)
Figure 39. Americas Nuclear Medicine Cyclotron Systems Sales Market Share by Country in 2025
Figure 40. Americas Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2020-2025)
Figure 41. Americas Nuclear Medicine Cyclotron Systems Sales Market Share byType (2020-2025)
Figure 42. Americas Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2020-2025)
Figure 43. United States Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Nuclear Medicine Cyclotron Systems Sales Market Share by Region in 2025
Figure 48. APAC Nuclear Medicine Cyclotron Systems Revenue Market Share by Region (2020-2025)
Figure 49. APAC Nuclear Medicine Cyclotron Systems Sales Market Share byType (2020-2025)
Figure 50. APAC Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2020-2025)
Figure 51. China Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 55. India Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Nuclear Medicine Cyclotron Systems Sales Market Share by Country in 2025
Figure 59. Europe Nuclear Medicine Cyclotron Systems Revenue Market Share by Country (2020-2025)
Figure 60. Europe Nuclear Medicine Cyclotron Systems Sales Market Share byType (2020-2025)
Figure 61. Europe Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2020-2025)
Figure 62. Germany Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 63.France Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Nuclear Medicine Cyclotron Systems Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Nuclear Medicine Cyclotron Systems Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Nuclear Medicine Cyclotron Systems Sales Market Share by Application (2020-2025)
Figure 70. Egypt Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Nuclear Medicine Cyclotron Systems Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Nuclear Medicine Cyclotron Systems in 2025
Figure 76. Manufacturing Process Analysis of Nuclear Medicine Cyclotron Systems
Figure 77. Industry Chain Structure of Nuclear Medicine Cyclotron Systems
Figure 78. Channels of Distribution
Figure 79. Global Nuclear Medicine Cyclotron Systems Sales MarketForecast by Region (2026-2031)
Figure 80. Global Nuclear Medicine Cyclotron Systems Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Nuclear Medicine Cyclotron Systems Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Nuclear Medicine Cyclotron Systems Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Nuclear Medicine Cyclotron Systems Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Nuclear Medicine Cyclotron Systems Revenue Market ShareForecast by Application (2026-2031)